London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
Oxford Nanopore Technologies
Chloe Goldsmith
)
- Job title
- Institution
- Translational Health Research Institute, Western Sydney University, Australia
- Biography
Chloe Goldsmith is an epigenetics researcher investigating the role of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) in immune cell identity and function. Her work focuses on the influence of DNA modifications on immune responses in autoimmune diseases and cancer immunity. By exploring the epigenetic regulation of immune cells, Chloe aims to uncover mechanisms driving immune dysfunction and discover potential therapeutic targets for disease.
- Recent publications
Goldsmith, C. et al. Single-Molecule DNA Methylation Reveals Unique Epigenetic Identity Profiles of T Helper Cells. The Journal of Immunology 212(6):1029–1039 (2024).
DOI: 10.4049/jimmunol.2300091Fesneau, O. et al. An intestinal TH17 cell-derived subset can initiate cancer. Nature Immunology 25:1637–1649 (2024).
DOI: 10.1038/s41590-024-01909-7
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.